DEMANT HLDG U/ADR (WILYY) analyst actions
Rating and price-target actions on WILYY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the WILYY overview →
No WILYY analyst action events in the measured window.
Nothing matched in the current window — the WILYY overview has every event we measure for this name.
Get an email when WILYY moves on news →Keep exploring
More WILYY: earnings → · SEC filings → · WILYY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SINO BIOPHARM ORD (SBMFF) | 48 | 0.00% | 4% |
| Theralase Technologies Inc (TLT_CDNX) | 48 | 0.00% | 18% |
| HLS THERAPEUTICS INC (HLTRF) | 47 | 0.00% | 24% |
| Eiger BioPharmaceuticals, Inc. (EIGR) | 45 | -1.57% | 32% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.